Management of breast papillary lesions diagnosed in ultrasound‐guided vacuum‐assisted and core needle biopsies

• DOI: 10.1111/his.12477
• Publication Date: 2014-07-05T16:01:17Z
• Authors: Rin Yamaguchi; Maki Tanaka; Gary M Tse; Miki Yamaguchi; Hiroshi Terasaki; Yoshitake Hirai; Yasuhide Nonaka; Michi Morita; Toshiro Yokoyama; Naoki Kanomata; Yoshiki Naito; Jun Akiba; Hirohisa Yano
• Keywords: Mammotome; Surgical excision

To assess the outcome of breast papillary lesions diagnosed by ultrasound-guided core needle biopsy (CB) or vacuum-assisted 'mammotome' (MT), accuracy these diagnoses, and whether it is justified not to undertake surgical excision non-malignant so diagnosed.Among 3219 (MT, 2195; CB, 1024) biopsies spanning 5 years, 185 (5.7%) [MT, 162 (88%); 23 (12%)] were identified. Of these, 142 cases (77%; MT/CB, 125/17) benign, 24 (13%, 23/1) atypical, 19 (10%; 14/5) malignant. benign cases, 114 had imaging follow-up (FU) (FU period 2-81 months); 17 excised, four malignant (3.5%) 4-57 months). atypical (23 FU), excised: six (32%) 13 (68%). The remaining considered be 7-54 months).Benign MT CB might require immediate excision, but should receive FU for at least years. Excision performed in showing changes features, as possibilities carcinoma coexisting with papilloma developing from cannot excluded, illustrated 4% upgrade rate this study.